Welcome to visit The Chinese Journal of Process Engineering, Today is
Biochemical Engineering

Security Evaluation of N-(2-Hydroxy)propyl-3-trimethylammonium Chitosan Chloride Microspheres as Parenteral Vaccine Adjuvant

  • WU Jing-jing WU Nan YUE Hua WU Xing-lan NAKANISHI Hideki GAO Xiao-dong MA Guang-hui
Expand
  • 1. School of Biotechnology, Jiangnan University
    2. National Key Lab. Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Science
    3. Beijing Institute of Petrochemical Technology
    4. State Key Lab. Biochem. Eng., Inst. Process Eng., Chinese Academy of Sciences

Received date: 2015-12-28

  Revised date: 2016-03-28

  Online published: 2016-10-10

Abstract

The safety evaluation of N-(2-hydroxy)propyl-3-trimethylammonium chitosan chloride (HTCC) microspheres as parenteral vaccine adjuvant was carried out in mice, rats, guinea pigs, rabbits. Mouse acute toxicity test showed that they have a high tolerance for over 50 times given clinical dose (5.0 mg/dose). Even high dosage of microspheres was injected in SD rats for many times, no pathological changes were found in their organ. The symptoms of mice in abnormal toxicity test were normal after injection. And the weight of mice increased significantly. In allergy test, no allergic reaction and symptoms were found in guinea pigs. And no fester and suppuration were found in muscle stimulation test. In the hemolysis results, red blood cell did not aggregate. All the tests proved good security of the HTCC microspheres.

Cite this article

WU Jing-jing WU Nan YUE Hua WU Xing-lan NAKANISHI Hideki GAO Xiao-dong MA Guang-hui . Security Evaluation of N-(2-Hydroxy)propyl-3-trimethylammonium Chitosan Chloride Microspheres as Parenteral Vaccine Adjuvant[J]. The Chinese Journal of Process Engineering, 2016 , 16(4) : 647 -653 . DOI: 10.12034/j.issn.1009-606X.215427

Outlines

/